Lunit Inc. completes acquisition of Volpara Health Technologies Ltd. to enhance cancer diagnostics capabilities
Acquiring Company
Lunit
Acquired Company
Volpara Health
Seoul
WellingtonHealth CareMedicalDescription
Lunit Inc., a South Korean cancer diagnostics AI company, has successfully completed the acquisition of Volpara Health Technologies Ltd., a New Zealand-based AI software developer for breast cancer detection. This strategic acquisition aims to improve Lunit’s cancer diagnostics capabilities and facilitate its expansion into the US market by integrating Volpara’s advanced breast health platform with its AI-powered solutions. The deal is valued at 264.7 billion won ($194 million) and is expected to broaden Lunit’s offerings to address a wider range of cancers and medical conditions.
Other recent acquisitions in Medical and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- CompuGroup Medical completes acquisition of AmbulApps GmbH to enhance digital solutions for patient care (June 19, 2024)
- Healthly completes acquisition and partnership with Lifestyle Medical to revolutionize healthcare (June 13, 2024)
- Dover Health expands into Illinois through acquisition of Centered Care Hospice and Palliative Care, and Cornerstone Home Health (June 6, 2024)
- DermCare Management acquires Longhorn Dermatology facilitated by Tinsley Medical Practice Brokers (May 29, 2024)
- Medical Guardian completes acquisition of MobileHelp, broadening senior health care solutions (May 1, 2024)
- West Physics completes acquisition of Tricord, Inc. to expand its medical and health physics services (April 26, 2024)
Who to call at Lunit, and when
When Lunit changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lunit raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lunit, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lunit. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lunit makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Volpara Health?
Volpara Health was acquired by Lunit, based in Seoul. The deal was reported on May 22, 2024. Through AI, Lunit aims to make data-driven medicine the new standard of care. Lunit is privately held.
When did Lunit acquire Volpara Health?
Lunit's acquisition of Volpara Health was reported on May 22, 2024. Lunit Inc., a South Korean cancer diagnostics AI company, has successfully completed the acquisition of Volpara Health Technologies Ltd., a New Zealand-based AI software developer for breast cancer detection. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Volpara Health do?
Volpara Health is on a mission to save families from cancer with AI-powered software that helps healthcare providers better understand cancer risk, guide personalized care decisions, and recommend additional imaging and interventions. It is privately held, operating in Health Care, and is based in Wellington.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.